NORTHSEA THERAPEUTICS NORWAY AS
Operating
Oppdagelse og utvikling av legemidler for kommersialisering.
Organization
- CEO
- EL
Emilie Lasson1963
- Chairman of the board
- Years since formation
- 10 years
- since Feb 3, 2016
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 6
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 3
- persons
Financials
- Total operating income 2025
- 20,353,477
- NOK
- Annual total result 2025
- 368,221
- NOK
- Total equity 2025
- 410,175
- NOK
Last update: Mar 18, 2026
Locations
- Company addressNydalsveien 15 0484 OSLO, NorgeCopied!
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
EL 1963 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
| - | 33.33 % directly | |
TS 1972 | - | 33.33 % directly |
DA | - | 33.33 % directly |
Last update: Nov 13, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
DA | Ordinary shares | 10,000 | 33.33 % |
| Ordinary shares | 10,000 | 33.33 % | |
TS 1972 | Ordinary shares | 10,000 | 33.33 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 20,353,477 | 19,328,156 | 18,617,360 | 15,773,081 |
Annual Total Result | 368,221 | 2,513 | 1,391 | -26,721 |
Total assets | 5,921,890 | 5,652,894 | 5,368,210 | 4,797,273 |
Total liabilities | 5,511,715 | 5,610,940 | 5,328,770 | 4,759,223 |
Total equity | 410,175 | 41,954 | 39,441 | 38,050 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 20,353,477 | 19,328,156 | 18,617,360 | 15,773,081 |
Total operating costs | 19,906,341 | 19,327,310 | 18,621,873 | 15,787,704 |
Operating result | 447,135 | 846 | -4,513 | -14,623 |
Financial income/costs | 31,473 | 20,343 | 23,395 | 246 |
Profit before tax | 478,608 | 21,189 | 18,882 | -14,377 |
Total tax & extraordinary income/cost | 110,387 | 18,676 | 17,491 | 12,344 |
Annual Total Result | 368,221 | 2,513 | 1,391 | -26,721 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 0 | 7,000 | 22,277 | 45,216 |
Total current assets | 5,921,890 | 5,645,894 | 5,345,933 | 4,752,057 |
Total assets | 5,921,890 | 5,652,894 | 5,368,210 | 4,797,273 |
Short term debt | 5,511,715 | 5,609,400 | 5,328,770 | 4,759,223 |
Long term debt | 0 | 1,540 | 0 | 0 |
Total liabilities | 5,511,715 | 5,610,940 | 5,328,770 | 4,759,223 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | 380,175 | 11,954 | 9,441 | 8,050 |
Total equity | 410,175 | 41,954 | 39,441 | 38,050 |
Total equity and liabilities | 5,921,890 | 5,652,894 | 5,368,210 | 4,797,273 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises